Pre-Open Stock Movers 09/16: (LPTX) (MDVL) (IO) Higher; (AERI) (BYND) (WYNN) Lower (more...)
- Nasdaq rises after strong Microsoft forecast
- Alphabet (GOOGL) Tops EPS and Revenue Estimates But Shares Dip on YouTube and Cloud Miss, Analysts See Positive Risk/Reward Despite High Expectations
- Oil drops more than 1% as U.S. stockpiles rise sharply
- Microsoft (MSFT) Stock Gains on Strong FQ1 Results and Guidance, Analysts Raise Price Targets on Azure and Windows Outperformance
- Goldman Sachs Expects Coca-Cola (KO) Stock to Outperform Today After Strong Q3 Results
Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.
Today's Pre-Open Movers:
Leap Therapeutics, Inc. (Nasdaq: LPTX) 24.9% HIGHER; announced the presentation of updated positive data from the first-line cohort of the DisTinGuish study, a Phase 2a clinical trial evaluating Leap's anti-Dickkopf-1 (DKK1) antibody, DKN-01, in combination with tislelizumab, BeiGene Ltd.'s anti-PD-1 antibody, and chemotherapy, in patients with gastric or gastroesophageal junction cancer (G/GEJ), at the European Society for Medical Oncology (ESMO) Congress. The Company will host a conference call on Friday, September 17, 2021 to discuss preliminary results from the study.
MedAvail Holdings, Inc. (Nasdaq: MDVL) 20.8% HIGHER; expects to open an initial four SpotRx locations in 2021 with IMA Medical Group in Florida.
ION Geophysical Corporation (NYSE: IO) 16.7% HIGHER; announced that its Board of Directors has initiated a process to evaluate a range of strategic alternatives to strengthen its financial position and maximize stakeholder value as the company continues to assess conditions in the capital markets and right-size the business. These strategic alternatives include, among others, a sale or other business combination transaction, sales of assets, private or public equity transactions, debt financing, or some combination of these.
Aerie Pharmaceuticals, Inc. (NASDAQ: AERI) 15.9% LOWER; reported positive topline results of its Phase 2b clinical study, named COMET-1, for AR-15512 (TRPM8 Agonist) (“AR-15512”) ophthalmic solution for the treatment of patients with dry eye disease. Management will host a conference call and provide accompanying slides to discuss these results at 5:00 p.m. ET today.
Laureate Education (NASDAQ: LAUR) 13.2% HIGHER; declared a special dividend of $7.01 per share.
Beyond Meat Inc. (NASDAQ: BYND) 2.9% LOWER; Piper Sandler downgraded from Neutral to Underweight with a price target of $95.00 (from $120.00).
Avis Budget Group (NASDAQ: CAR) 2.9% HIGHER; BofA Securities upgraded from Neutral to Buy with a price target of $125.00 (from $90.00).
Wynn Resorts (NASDAQ: WYNN) 2.8% LOWER; JPMorgan downgraded from Overweight to Neutral with a price target of $89.00 (from $122.00).
Shares of Electronic Arts (NASDAQ: EA) 2.7% LOWER; closed down 5.7% Wednesday on rumors Battlefield 2042 will be delayed. However, shares are trading around 2.7% higher after-hours after confirming the news but still keeping the launch this year. The company is also reiterating its net bookings guidance despite the delay.
Las Vegas Sands Corp. (NYSE: LVS) 2.3% LOWER; JPMorgan downgraded from Overweight to Neutral with a price target of $89.00 (from $122.00).
aTyr Pharma, Inc. (Nasdaq: LIFE) 0.8% LOWER; announced that it has commenced an underwritten public offering of shares of its common stock.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Pre-Open Stock Movers 10/27: (ENPH) (TENB) (FFIV) Higher; (CRTX) (HOOD) (TXN) Lower (more...)
- Lucid Group (LCID) Climbs 5% Pre-Open
- General Motors (GM) Beats Q3 Views, Shares Dip on EPS Outlook Miss, Analyst Remains Upbeat
Create E-mail Alert Related CategoriesSpecial Reports
Related EntitiesJPMorgan, Pre-Open Losers, Pre-Open Winners, Pre Market Movers
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!